-
Je něco špatně v tomto záznamu ?
The expanding role of primary care in cancer control
G. Rubin, A. Berendsen, SM. Crawford, R. Dommett, C. Earle, J. Emery, T. Fahey, L. Grassi, E. Grunfeld, S. Gupta, W. Hamilton, S. Hiom, D. Hunter, G. Lyratzopoulos, U. Macleod, R. Mason, G. Mitchell, RD. Neal, M. Peake, M. Roland, B. Seifert, J....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
ProQuest Central
od 2000-09-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2000-09-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
- MeSH
- lidé MeSH
- nádory terapie MeSH
- poskytování zdravotní péče metody MeSH
- primární zdravotní péče metody MeSH
- zdravotnické služby - potřeby a požadavky * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise—from epidemiologists, psychologists, policy makers, and cancer specialists—has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care—its continuous, coordinated, and comprehensive care for individuals and families—are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.
Airedale National Health Service Foundation Trust Keighley UK
American Cancer Society Atlanta GA USA
Centre for Population Health Sciences University of Edinburgh Edinburgh UK
Department of Biomedical and Specialty Surgical Sciences University of Ferrara Ferrara Italy
Department of Clinical Health Care Oxford Brookes University Oxford UK
Department of Epidemiology and Public Health University College London London UK
Department of Family Medicine University of Manitoba Winnipeg MB Canada
Department of General Practice Charles University Prague Czech Republic
Department of General Practice University Medical Center Utrecht Utrecht Netherlands
Department of General Practice University of Groningen Groningen Netherlands
Department of General Practice University of Melbourne Melbourne VIC Australia
Department of Paediatrics University of Toronto Toronto ON Canada
Department of Public Health Aarhus University Aarhus Denmark
Department of Public Health and Primary Care University of Cambridge Cambridge UK
Division of Cancer Control and Population Sciences National Cancer Institute Bethesda MD USA
Faculty of Life Sciences and Medicine King's College London London UK
Faculty of Medicine and Biomedical Sciences University of Queensland Brisbane QLD Australia
Faculty of Medicine University of Toronto Toronto ON Canada
Glenfield Hospital Leicester UK
Hull York Medical School University of Hull Hull UK
Institute of Health Policy Management and Evaluation University of Toronto Toronto ON Canada
Juravinski Cancer Centre Hamilton ON Canada
Medical School University of Exeter Exeter UK
North Wales Centre for Primary Care Research Bangor University Bangor Wales
Ontario Institute for Cancer Research Toronto ON Canada
Research Department of Oncology University College London London UK
Royal College of Surgeons in Ireland Dublin Ireland
School of Clinical Sciences University of Bristol Bristol UK
School of Medicine Pharmacy and Health Durham University Stockton on Tees UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16009942
- 003
- CZ-PrNML
- 005
- 20160418121653.0
- 007
- ta
- 008
- 160408s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1470-2045(15)00205-3 $2 doi
- 024 7_
- $a 10.1016/S1470-2045(15)00205-3 $2 doi
- 035 __
- $a (PubMed)26431866
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Rubin, Greg $u School of Medicine, Pharmacy and Health, Durham University, Stockton on Tees, UK. Electronic address: g.p.rubin@durham.ac.uk.
- 245 14
- $a The expanding role of primary care in cancer control / $c G. Rubin, A. Berendsen, SM. Crawford, R. Dommett, C. Earle, J. Emery, T. Fahey, L. Grassi, E. Grunfeld, S. Gupta, W. Hamilton, S. Hiom, D. Hunter, G. Lyratzopoulos, U. Macleod, R. Mason, G. Mitchell, RD. Neal, M. Peake, M. Roland, B. Seifert, J. Sisler, J. Sussman, S. Taplin, P. Vedsted, T. Voruganti, F. Walter, J. Wardle, E. Watson, D. Weller, R. Wender, J. Whelan, J. Whitlock, C. Wilkinson, N. de Wit, C. Zimmermann,
- 520 9_
- $a The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise—from epidemiologists, psychologists, policy makers, and cancer specialists—has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care—its continuous, coordinated, and comprehensive care for individuals and families—are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.
- 650 _2
- $a poskytování zdravotní péče $x metody $7 D003695
- 650 12
- $a zdravotnické služby - potřeby a požadavky $7 D006301
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory $x terapie $7 D009369
- 650 _2
- $a primární zdravotní péče $x metody $7 D011320
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Berendsen, Annette $u Department of General Practice, University of Groningen, Groningen, Netherlands.
- 700 1_
- $a Crawford, S Michael $u Airedale National Health Service Foundation Trust, Keighley, UK.
- 700 1_
- $a Dommett, Rachel $u School of Clinical Sciences, University of Bristol, Bristol, UK.
- 700 1_
- $a Earle, Craig $u Ontario Institute for Cancer Research, Toronto, ON, Canada.
- 700 1_
- $a Emery, Jon $u Department of General Practice, University of Melbourne, Melbourne, VIC, Australia.
- 700 1_
- $a Fahey, Tom $u Royal College of Surgeons in Ireland, Dublin, Ireland.
- 700 1_
- $a Grassi, Luigi $u Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy.
- 700 1_
- $a Grunfeld, Eva $u Ontario Institute for Cancer Research, Toronto, ON, Canada.
- 700 1_
- $a Gupta, Sumit $u Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
- 700 1_
- $a Hamilton, Willie $u Medical School, University of Exeter, Exeter, UK.
- 700 1_
- $a Hiom, Sara $u Cancer Research UK, London, UK.
- 700 1_
- $a Hunter, David $u School of Medicine, Pharmacy and Health, Durham University, Stockton on Tees, UK.
- 700 1_
- $a Lyratzopoulos, Georgios $u Department of Epidemiology and Public Health, University College London, London, UK.
- 700 1_
- $a Macleod, Una $u Hull-York Medical School, University of Hull, Hull, UK.
- 700 1_
- $a Mason, Robert $u Faculty of Life Sciences and Medicine, King's College London, London, UK.
- 700 1_
- $a Mitchell, Geoffrey $u Faculty of Medicine and Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.
- 700 1_
- $a Neal, Richard D $u North Wales Centre for Primary Care Research, Bangor University, Bangor, Wales.
- 700 1_
- $a Peake, Michael $u Glenfield Hospital, Leicester, UK.
- 700 1_
- $a Roland, Martin $u Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Seifert, Bohumil $u Department of General Practice, Charles University, Prague, Czech Republic.
- 700 1_
- $a Sisler, Jeff $u Department of Family Medicine, University of Manitoba, Winnipeg, MB, Canada.
- 700 1_
- $a Sussman, Jonathan $u Juravinski Cancer Centre, Hamilton, ON, Canada.
- 700 1_
- $a Taplin, Stephen $u Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
- 700 1_
- $a Vedsted, Peter $u Department of Public Health, Aarhus University, Aarhus, Denmark.
- 700 1_
- $a Voruganti, Teja $u Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- 700 1_
- $a Walter, Fiona $u Department of General Practice, University of Groningen, Groningen, Netherlands.
- 700 1_
- $a Wardle, Jane $u Department of Epidemiology and Public Health, University College London, London, UK.
- 700 1_
- $a Watson, Eila $u Department of Clinical Health Care, Oxford Brookes University, Oxford, UK.
- 700 1_
- $a Weller, David $u Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
- 700 1_
- $a Wender, Richard $u American Cancer Society, Atlanta, GA, USA.
- 700 1_
- $a Whelan, Jeremy $u Research Department of Oncology, University College London, London, UK.
- 700 1_
- $a Whitlock, James $u Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
- 700 1_
- $a Wilkinson, Clare $u North Wales Centre for Primary Care Research, Bangor University, Bangor, Wales.
- 700 1_
- $a de Wit, Niek $u Department of General Practice, University Medical Center Utrecht, Utrecht, Netherlands.
- 700 1_
- $a Zimmermann, Camilla $u Division of Medical Oncology and Haematology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
- 773 0_
- $w MED00011558 $t The Lancet. Oncology $x 1474-5488 $g Roč. 16, č. 12 (2015), s. 1231-72
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26431866 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160418121740 $b ABA008
- 999 __
- $a ok $b bmc $g 1113371 $s 934310
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 16 $c 12 $d 1231-72 $i 1474-5488 $m Lancet oncology $n Lancet Oncol. $x MED00011558
- LZP __
- $a Pubmed-20160408
